AMGEN INC·4

May 11, 7:39 PM ET

Bradway Robert A 4

4 · AMGEN INC · Filed May 11, 2026

Research Summary

AI-generated summary of this filing

Updated

Amgen (AMGN) CEO Robert A. Bradway Withholds 2,079 Shares

What Happened
Robert A. Bradway, Amgen's Chairman, CEO and President, had 2,079 shares withheld to cover a tax liability related to equity awards. The shares were valued at $331.11 each, for a total of approximately $688,378. This disposition reflects tax withholding (transaction code F), not an open-market sale.

Key Details

  • Transaction date: 2026-05-07; Form 4 filed: 2026-05-11 (filed within the standard two business-day window).
  • Shares withheld/disposed: 2,079 shares at $331.11 per share; total value ≈ $688,378.
  • Shares owned after transaction: Not reported in the provided filing excerpt.
  • Footnote: 1,273 of the withheld shares were Dividend Equivalents (DEs) credited to unvested Restricted Stock Units and paid out in shares on a one-to-one basis per the vesting schedule (with cash for any fractional share).
  • Transaction type: Tax withholding on equity awards (routine administrative action), not a purchase (code F).

Context
Withholding shares to cover taxes on vested awards is a common administrative step and is generally considered routine rather than a signal of the insider’s view on the stock. The filing indicates these were linked to RSU-related dividend equivalents; no open-market sale or 10b5‑1 plan was reported in the provided excerpt.

Insider Transaction Report

Form 4
Period: 2026-05-07
Bradway Robert A
DirectorChairman, CEO and President
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-05-07$331.11/sh2,079$688,378505,160 total
Holdings
  • Common Stock

    (indirect: By GRAT)
    60,060
  • Common Stock

    (indirect: By Spousal GRAT)
    60,060
  • Common Stock

    (indirect: By Spouse)
    29,940
Footnotes (1)
  • [F1]These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Signature
/s/ Robert A. Bradway|2026-05-08

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT